Professor Lisa Anderson
Lisa Anderson (Consultant cardiologist, St George’s University Hospitals NHS Trust and City St George’s, University of London) is the Past Chair of the British Society for Heart Failure and chairs the NHS England Heart Failure Expert Advisory Group. She led the project to open the UK's first Acute Heart Failure Unit in 2016 and wrote the proposal for the National Confidential Enquiry (NCEPOD) into UK deaths in Acute Heart Failure.

She was the clinical expert for UK NICE Technology Appraisals (TA10946, TA10942, TA388) and for the BMA Expert Review Group for TA267, is a member of the Executive Committee for CaReMe UK and sits on the Health Innovations Network Programme Board.

Lisa is the National Lead Investigator for the Moonraker Programme and National Coordinating Investigator for CONFIRMATION-HF, Co-Investigator for POLARIS, MARITIME and BRANCH-HF and has ongoing research interests in V142I ATTR, acute heart failure and the complex interplay between heart and kidney dysfunction. She developed T2* imaging for the detection of cardiac iron, and the original publication remains one of the most highly cited in the field. The T2* sequence has since become the international standard and is now implemented on CMR scanners from all major vendors worldwide.

Mrs Carys Barton
Carys Barton (Heart Failure Nurse Consultant, Imperial College NHS Foundation Trust, London) is the Chair of British Society for Heart Failure (BSH) and the first nurse in this position. Prior to this, she was deputy Chair of BSH, Chair BSH Nurse Forum 2019–21 and a board observer from 2017–19. Other positions currently held are Honorary Secretary and council member of the British Association for Nurses in Cardiac Care (BANCC), Committee Member of the British Geriatrics Society (BGS) Cardiovascular Special Interest Group, the Heart Failure Policy Network steering committee, Pumping Marvellous clinical committee, and the Cardiorenal Forum scientific committee. She is committed to supporting the education and development of heart failure specialist nurses and allied health professionals, through the BSH and the nurse forum but also as an honorary lecturer of heart failure masters modules at Glasgow Caledonian University and Keele University.

Dr Sarah Birkhoelzer
Sarah Birkhoelzer (Heart Failure and Imaging Fellow, University Hospitals Dorset, Bournemouth) specialises in heart failure and magnetic resonance imaging (MRI) with a particular sub-speciality interest of amyloidosis. As part of her PhD at the University of Oxford, she examined cardiac and skeletal muscle metabolism in heart failure. She completed a research fellowship at Brigham and Women’s Hospital, Boston, USA, under Dr Scott Solomon, Professor of Medicine at Harvard University Medical School.She is the UK Heart Failure Association (HFA) Young Ambassador and serves on the British Cardiovascular Society Practice and Guidelines, and Women in Cardiology Committees. A confident public speaker, she presents widely and hosts the patient-facing BEATWISE podcast, aiming to bridge clinical knowledge and patient experience. Her work has received multiple awards and funding from both industry and charities.

Dr Kevin Cheng
Kevin Cheng (Cardiology Registrar, North West London Deanery) recently completed a British Heart Foundation Clinical Research Training Fellowship at the Royal Brompton Hospital and Imperial College London. His work focuses on novel diagnostics and treatments for refractory angina, invasive and non-invasive assessment of ANOCA, and coronary sinus reducer implantation. He led the BHF-funded REMEDY-PILOT trial, a randomised, double-blind, sham-controlled study of the coronary sinus reducer in microvascular angina. For postgraduate training, he was awarded an NIHR-funded Academic Clinical Fellowship and Academic Foundation Program at Imperial College London having qualified from the University of Oxford.

Professor Indranil Dasgupta
Indranil Dasgupta (Consultant in Renal Medicine and Hypertension, University Hospitals Birmingham NHS Foundation Trust; School of Health Sciences, University of Birmingham) is a clinical academic in nephrology and hypertension. His research interests include resistant hypertension, diabetic kidney disease, cognitive impairment in kidney disease, and fluid and BP management in dialysis. He is the current Research Chair of the British and Irish Hypertension Society (BIHS) and Co-Chair of UK Kidney Research Consortium (UKKRC) Diabetes and CKD Study Group. He is a member of the CaReMe UK Executive Committee and RCP London Cardio-Metabolic Disease Steering Group.

Ms Wendy Gin-Sing
Wendy Gin-Sing (Pulmonary Hypertension Nurse Consultant, Imperial College Healthcare NHS Trust) has a foundation in coronary care and high dependency nursing. She has specialised in pulmonary hypertension since 2000 and plays an active role in research to advance evidence-based practice and improve patient outcomes. She advocates a holistic approach to care, recognising the impact of chronic illness on both patients and their families. She serves as Deputy Chair of the UK Pulmonary Hypertension Professionals Forum and Co-Chair of the PVRI Patient Engagement and Empowerment Workstream, contributing to national and international efforts to enhance patient care. Wendy has participated in numerous advisory groups, steering committees, and workshops, and has published and presented widely across leading professional forums.

Professor Claire Hills
Claire Hills (Professor of Renal Physiology and Head of the Cardio-Renal Team, University of Lincoln) gained a PhD in Molecular Physiology from the University of Warwick and has internationally recognised expertise in chronic kidney disease, particularly diabetic nephropathy. Her research focuses on mechanisms underlying kidney disease progression, with emphasis on targeting late-stage damage and connexin-mediated cell communication to alleviate inflammation and fibrosis. She has received major grant awards, serves on the Diabetes UK complications panel, is Basic Science Editor for Diabetic Medicine, and leads collaborative clinical research, including an ongoing RCT with the Lincolnshire Heart Centre.

Professor Paul Kalra
Paul Kalra (Consultant Cardiologist, Portsmouth Hospitals University NHS Trust) is one of the founders of the Cardiorenal Forum and past Chair of the British Society for Heart Failure. His research interests include the role of iron deficiency and its correction in patients with heart failure, cardiorenal disease and the impact of hyperkalaemia on RAAS inhibition use.

Professor Philip Kalra
Philip Kalra (Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester) graduated from Cambridge University and St Thomas’s Hospital Medical School. He is Director of Research and Innovation in the Northern Care Alliance, the trust encompassing Salford Royal where he has been Consultant Nephrologist since 1995. He was Academic Vice-President of the UK Renal Association from 2016–19, Chair of the UK Kidney Research Consortium during this time and was Chair of the National Institute for Health Research CRN Renal Disorders group from 2010 until 2018. He is the lead of the Donal O’Donoghue Renal Research Centre, the local research centre named in honour of our late esteemed colleague. He has major research interests in CKD progression, intravenous iron in CKD, renovascular disease and renal epidemiology, and he has been involved in the development of several large UK clinical trials in nephrology and cardiology. These include the ASTRAL, PIVOTAL and IRONMAN trials and the NURTuRE cohort. He has played a role in improving collaboration between nephrology and cardiology in both scientific and educational endeavours.

Dr David Lappin
David Lappin (Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway) graduated in Dublin in 1991. He trained in nephrology in Dublin and Manchester and obtained a PhD in Medicine in 2002. He is a Consultant Nephrologist/Honorary Personal Professor of Nephrology at Galway University Hospitals/National University of Ireland, Galway. His areas of interest are clinical nephrology, diabetic nephropathy and resistant hypertension. He is the President of the European Union of Medical Specialists (UEMS) Section of Nephrology, the current UEMS lead for the European Specialty Examination in Nephrology, and former member of the European Renal Association CME subcommittee.

Mr Muhammad Khalid Lodhi
Muhammad Khalid Lodhi (Lead Pharmacist, Cardiology and Medicine, University Hospitals Plymouth NHS Trust) has a special interest in lipids management and heart failure medicines optimisation. He has an MSc in Advanced Clinical Practice and a Postgraduate Diploma in Preventive Cardiovascular Diseases.

Professor Julie Lovegrove
Julie Lovegrove (Professor of Human Nutrition and Director of the Hugh Sinclair Unit of Human Nutrition, University of Reading) looks at diet and cardiometabolic risk in her research with an interest in personalised nutrition and sustainability. Julie serves on several external committees, is Chair of the UK government's Scientific Advisory Committee for Nutrition and is a member of the Medical Research Council’s Population and Systems Medical Board. She was President of The Nutrition Society of UK and Ireland (2019–2023) and Vice-President of the Association of Nutrition (2016–2019). Julie received the British Nutrition Foundation Award (2022) and the Venus International Women’s Distinguished Researcher Award (2025).

Professor Gerry McCann
Gerry McCann is the cardiovascular theme lead for the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre. Gerry was a full-time NHS Consultant Cardiologist before undertaking successive NIHR research fellowships since 2011. He directs a very active clinical imaging research programme with funding from the British Heart Foundation, the Medical Research Council and his NIHR Research Professorship is focused on the prevalence of heart failure in a multi-ethnic population with type 2 diabetes and how best to diagnose and prevent symptom onset, working closely with researchers from the Leicester Diabetes Centre.

Professor Alex Miras
Alex Miras (Professor of Endocrinology, Ulster University, Derry) focuses solely on obesity and type 2 diabetes in his clinical and research work. He has contributed to clinical management policy and research in the field of obesity over the last 16 years. His research group’s specialist interests are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices, and obesity surgery.

Dr Geraint Morton
Geraint Morton (Consultant Cardiologist and Cardiology Clinical Director, Portsmouth Hospitals University NHS Trust) has sub-specialty interests in heart failure and implantable cardiac devices. His research interests include cardiac MRI and, more recently, organisation and pathways of care in cardiology.

Dr David Mulcahy
David Mulcahy (Consultant Cardiologist, Blackrock Health Hermitage Clinic, Dublin) qualified from the Royal College of Surgeons, Dublin, and trained in London and Bethesda before returning to Ireland as a Consultant Cardiologist in the Adelaide and Meath Hospital, Dublin. He then moved to Tallaght Hospital in 2000, and founded the clinical CRY Unit in conjunction with the charity Cardiac Risk in the Young in 2007.

Professor Jonathan Murray
Jonathan Murray is a Consultant Nephrologist, South Tees NHS Foundation Trust, and Honorary Professor in the School of Health and Life Sciences, Teesside University, Middlesbrough.

Miss Kathrine Parker
Kathrine Parker (Highly Specialist Renal Pharmacist, Manchester University NHS Foundation Trust; Honorary Lecturer, University of Manchester) received a personal funding award from the NIHR to investigate anticoagulant use in CKD as part of a clinical academic doctoral fellowship. She developed two national guidelines via the UK Kidney Association with support from the British Cardiovascular Society and British Society Haematology. Her other interests include drug dosing in dialysis and symptom management in advanced kidney disease. Kathrine prescribes for patients on the dialysis unit and in renal outpatient clinics. She is the UK Kidney Association Academic Vice President and incoming Chair for the UK Renal Pharmacy Group.

Professor Smeeta Sinha
Smeeta Sinha (Consultant Nephrologist at Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Greater Manchester) leads the complex glomerulonephritis service. She is NHS England National Clinical Director for renal medicine and an Honorary Professor at the University of Manchester. Her clinical and research work includes vascular calcification, multi morbidity and glomerulonephritis.

Ms Angelique Smit
Angelique Smit (Lead Clinical and Research Nurse, National Amyloidosis Centre, Royal Free London NHS Foundation Trust) has over 20 years of dedicated service at the Royal Free and brings a wealth of experience and expertise to her role. Her clinical background is rooted in cardiac care, with a strong foundation in cath lab procedures and patient management. Throughout her career, Angelique has played a key role in advancing both patient care and clinical research, bridging the gap between frontline healthcare delivery and innovative clinical studies. Her leadership, deep clinical knowledge, and commitment to excellence continue to drive high standards in nursing practice and research coordination across multidisciplinary teams.

Dr Pauline Swift
Pauline Swift (Consultant Nephrologist, Associate Medical Director for Research and Education, Epsom and St Helier University Hospitals NHS Trust) is the Cardio-Renal Metabolic co-lead for South West London. She looks after patients with all stages of chronic kidney disease (CKD) and has a specialist interest in high blood pressure/hypertension. She provides clinics in general nephrology, hypertension and cardio-renal-metabolic disease. She is a Fellow of the British and Irish Hypertension Society (BIHS) and Chair of the patients’ charity Blood Pressure UK (BPUK). Her own research interests include hypertension, kidney disease and cardiovascular risk and the delivery of clinical trials in hypertension, CKD and diabetic kidney disease. She advocates for improved patient education and access to supported self-management to achieve better long term cardiovascular and kidney health, with improved blood pressure management a fundamental part of that ambition..

Dr Andreas Tridimas
Andreas Tridimas (Consultant in Chemical Pathology and Metabolic Medicine, Wirral University Teaching Hospital and Countess of Chester Hospital NHS Trusts) also leads lipid services at Arrowe Park Hospital and serves as Lipid Lead for the Cheshire and Merseyside Pathology Network. His work centres on cardiovascular disease prevention, with a particular focus on lipoprotein(a) and residual risk. He is involved in national work with HEART UK and is developing scalable NHS pathways to support implementation of lipoprotein(a) testing and management ahead of emerging therapies.